Fingerprint
Dive into the research topics of 'Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically